The pharmacological and clinical research of a new drug, pyracoine phosphate, for rescuing fulminant cerebral malaria
Zhonghua Nei Ke Za Zhi 20(3): 180-181
1981
ISSN/ISBN: 0578-1426 PMID: 7307739 Document Number: 168823
Document emailed within 1 workday
Related Documents
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737Chadee, D.D.; Tilluckdharry, C.C.; Doon, R. 1996: Imported cerebral malaria complicated with glucose-6-phosphate dehydrogenase deficiency West Indian Medical Journal 45(3): 97-99
Ohmori, S.; Shiraki, K.; Inoue, H.; Okano, H.; Yamanaka, T.; Deguchi, M.; Sakai, T.; Takase, K.; Nakano, T.; Tameda, Y. 2003: Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure Hepato-Gastroenterology 50(53): 1531-1534
Nantulya, F.N.; Kengeya-Kayondo, J.F.; Ogundahunsi, O.A.T. 2007: Research themes and advances in malaria research capacity made by the Multilateral Initiative on Malaria American Journal of Tropical Medicine and Hygiene 77(6 Suppl): 303-313
May, B.; Helmstaedt, D. 1975: Liver disease in drug addicts: clinical course-toxicological and clinical pharmacological aspects International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 50-56
Mager, P.P. 1975: MASCA-model of the biochemical-pharmacological drug research. Part 3: Structure-activity relationships and KANORA Arzneimittel-Forschung 25(9): 1355-1356
Mager, P.P. 1975: MASCA-model of the biochemical-pharmacological drug research / part 5: Structure-activity relationships and MACOVA Arzneimittel-Forschung 25(11): 1745
Rossouw, J.E.; Labadarios, D.; McConnell, J.B.; Davis, M.; Williams, R. 1977: Plasma pyridoxal phosphate levels in fulminant hepatic failure and the effects of parenteral supplementation Scandinavian Journal of Gastroenterology 12(1): 123-127
Ahsan, T.; Rab, S.M.; Shekhani, M.S. 1993: Falciparum malaria or fulminant hepatic failure? Jpma. Journal of the Pakistan Medical Association 43(10): 206-208
Beck, O.A.; Spielmann, H.; Witt, E.; Oeff, M.; Liddard, C.; Hochrein, H. 1980: Anti-arrhythmic effect of dazolicin. Clinical-pharmacological research Arzneimittel-Forschung 30(12): 2172-2181
Gupta, O.K.; Sikka, K.K. 1984: Plasmodium falciparum malaria and acute fulminant hepatitis Journal of the Association of Physicians of India 32(10): 921
Esamai, F.; Nabakwe, E.; Mining, S.; Forsberg, P.; Lewis, D.H. 1999: Clinical presentation and diagnosis of cerebral malaria in children in the highlands of western Kenya East African Medical Journal 76(2): 89-92
Olweny, C.L.; Chauhan, S.S.; Simooya, O.O.; Bulsara, M.K.; Njelesani, E.K.; Van Thuc, H. 1986: Adult cerebral malaria in Zambia: preliminary report of clinical findings and treatment response Journal of Tropical Medicine and Hygiene 89(3): 123-129
Walde, N.H.; Bjorvatn, B. 1982: Chloroquine resistant falciparum malaria in East Africa illustrated by a case of cerebral malaria Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(29): 1491-1492
Nacher, M.; Treeprasertsuk, S.; Singhasivanon, P.; Silachamroon, U.; Vannaphan, S.; Gay, F.; Looareesuwan, S.; Wilairatana, P. 2001: Association of hepatomegaly and jaundice with acute renal failure but not with cerebral malaria in severe falciparum malaria in Thailand American Journal of Tropical Medicine and Hygiene 65(6): 828-833
Trinus, F.P.; Mokhort, N.A. 1979: Pharmacological and clinical aspects of mefenamic acid--nonsteroid anti-inflammatory drug (review of the literature) Vrachebnoe Delo 1979(3): 34-39
Bender, K.I.; Lutsevich, N.F.; Lutsevich, A.N. 1991: The clinical and pharmacological significance of drug binding by blood plasma proteins in the mother-placenta-fetus system Vrachebnoe Delo 11: 35-41
Roussel, H.; Lo Re, G.èv.; Honorat, C.; Alonso, M.èl.; Sciortino, V. 2006: The use of triptan in ambulatory medicine in Midi-Pyrénées Region: clinical and pharmacological contra-indications and drug abuse Therapie 61(6): 507-516
Nishizawa, Y. 1993: The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 389-396
Vítová, Z. 1970: Cerebral responses to flickering light in clinical research Activitas Nervosa Superior 12(2): 162